This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Universitätsmedizin Der Johannes Gutenberg-Universitat Mainz. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Natascha Stergiou: Innovator in Cancer Research
Introduction
Natascha Stergiou is a prominent inventor based in Mainz, Germany. She has made significant contributions to the field of cancer research through her innovative work on peptide-based compounds. Her research focuses on developing solutions for the prevention, treatment, and detection of cancer.
Latest Patents
Natascha Stergiou holds a patent for her invention titled "Peptide-based compounds for use in the prevention, treatment and/or detection of cancer." This patent describes a compound that includes a first polypeptide sequence with at least three different amino acid sequences selected from specific groups. Additionally, it features a second polypeptide sequence with its own set of amino acid sequences. The compound is designed to bind to tumor-associated Mucin-1 (TA-MUC1), which is crucial in cancer research. She has 1 patent to her name.
Career Highlights
Throughout her career, Natascha has worked at esteemed institutions such as Universitätsmedizin der Johannes Gutenberg-Universität Mainz and Johannes Gutenberg-Universität Mainz. Her work in these organizations has allowed her to advance her research and contribute to the scientific community.
Collaborations
Natascha has collaborated with notable colleagues, including Nikola Gaidzik and Edgar Schmitt. These partnerships have enriched her research and expanded the impact of her work in the field of cancer treatment.
Conclusion
Natascha Stergiou is a dedicated inventor whose work in peptide-based compounds is paving the way for advancements in cancer prevention and treatment. Her contributions are vital to the ongoing fight against cancer, and her innovative spirit continues to inspire others in the field.